Literature DB >> 17098769

Fear of venepuncture as a barrier to testing for blood-borne infection and use of an oral fluid test as an alternative to venepuncture in a genitourinary medicine clinic.

H L McClean1, A J Taylor, A M Mortimer.   

Abstract

OBJECTIVE: A survey of 505 consecutive patients attending a UK genitourinary medicine clinic (GUM) included a psychometric tool to compute a fear of venepuncture (FOV) score, responses to the offer of venepuncture and to alternative testing.
METHOD: An oral fluid test (OFT) was available to test for blood-borne infection (BBI). Completed fear scores were provided by 299 (59%) patients routinely offered venepuncture, of whom 72 (24%) who did not have venepuncture had higher fear scores compared with 227 (76%) who had venepuncture (p<0.001).
RESULTS: Both FOV and female sex were independent predictors of not having venepuncture.
CONCLUSIONS: FOV is an important barrier to uptake of venepuncture. FOV may not always be recognised by health carers. OFT is an acceptable alternative test for some patients with needle aversion who decline venepuncture.

Entities:  

Mesh:

Year:  2006        PMID: 17098769      PMCID: PMC2598587          DOI: 10.1136/sti.2006.020974

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  5 in total

1.  Screening for HIV infection in genitourinary medicine clinics: a lost opportunity? British Co-operative Clinical Group.

Authors: 
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

2.  The acceptability of oral fluid testing for HIV antibodies. A pilot study in gay bars in a predominantly rural state.

Authors:  F S Sy; S D Rhodes; S T Choi; D Drociuk; A A Laurent; R M Naccash; L D Kettinger
Journal:  Sex Transm Dis       Date:  1998-04       Impact factor: 2.830

3.  Development and validation of the diabetes fear of injecting and self-testing questionnaire (D-FISQ): first findings.

Authors:  F J Snoek; E D Mollema; R J Heine; L M Bouter; H M van der Ploeg
Journal:  Diabet Med       Date:  1997-10       Impact factor: 4.359

Review 4.  Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come.

Authors:  D Malamud
Journal:  Am J Med       Date:  1997-04-01       Impact factor: 4.965

5.  The acceptability of the introduction of a type specific herpes antibody screening test into a genitourinary medicine clinic in the United Kingdom.

Authors:  H M Mullan; P E Munday
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.